Villablanca, Judith G. et al
"Phase II Study of Oral Capsular 4-Hydroxyphenylretinamide (4-HPR/Fenretinide) in Pediatric Patients with Refractory or Recurrent Neuroblastoma: A Report from the Children's Oncology Group." Clinical Cancer Research
17.21
(2011):
6858-6866.
Web. 04 Mar. 2021.
